Response vs. Effect: Benedetti's Crucial Distinction in the Neuroscience of Belief

The Word That Hides a Mechanism

For decades, “the placebo effect” has functioned as a kind of scientific shrug—a catch-all term for anything that happens when someone gets better (or worse) despite receiving an inert substance. This vagueness has cost the field dearly. It has allowed skeptics to dismiss placebo phenomena as statistical noise, and it has allowed enthusiasts to overstate what a sugar pill can actually do. Fabrizio Benedetti, one of the most rigorous voices in the neuroscience of expectation, spent his career trying to clean up this mess. In a concise 2025 paper published in EULAR Rheumatol Open, he restates a distinction that should be foundational to anyone studying mind-body medicine, meditation research, or the biology of belief: the difference between a placebo response and a placebo effect.

This is not semantic hairsplitting. It is the difference between measuring an outcome and understanding a mechanism—and that difference determines whether we can ever answer the question every contemplative tradition has implicitly asked: can a change in mental state produce a measurable change in the body?

Two Different Things Wearing the Same Name

Benedetti’s framing is elegant in its simplicity. When a patient receives a placebo and their symptoms improve, that improvement—the placebo response—is a grab-bag of causes. It includes:

• Spontaneous remission — the illness was going to improve on its own
• Regression to the mean — people tend to seek treatment when symptoms are at their worst, so any measurement afterward looks like improvement
• Reporting bias — patients and experimenters unconsciously shape what they notice and record
• Co-interventions — other treatments, lifestyle changes, or attention effects happening in parallel
• Psychological factors — genuine expectation and conditioning effects on the brain

The placebo effect, by contrast, refers only to that last item: the specific, identifiable psychobiological change driven by the patient’s expectations and prior learning history. Benedetti draws a precise parallel to pharmacology—the difference between a drug’s response (everything that happens after you take it, confounds included) and a drug’s effect (its actual pharmacodynamic action on receptors and tissues). Nobody would confuse a drug’s total clinical outcome with its mechanism of action. Yet in placebo research, this conflation happens constantly.

The same logic applies in reverse to the nocebo phenomenon—when expectation of harm produces genuine adverse effects. A nocebo response includes the same noise (misattributed symptoms, natural disease progression) layered over a genuine nocebo effect: real, expectation-driven suffering, sometimes with measurable physiological correlates in the HPA axis and pain-processing circuitry.

Why This Matters More Than It Sounds Like It Should

Benedetti identifies two consequences of this distinction, and both radiate outward from clinical trial design into the broader science of consciousness.

First, for regulatory science, the placebo response is what matters. A randomized controlled trial needs to know whether a drug outperforms everything that happens in a placebo arm—biases, regression to the mean, and all. This is why placebo-controlled trials exist: not to isolate a mechanism, but to establish that a treatment does something beyond the sum of confounds.

Second, and this is where it gets interesting for anyone studying meditation, ritual, or altered states—the placebo effect is what matters if you want to understand the brain. If we want to know what expectation actually does to neural circuitry, we cannot study it through the murky lens of the total clinical response. We need designs that isolate expectation and conditioning as independent variables, then look at what changes in the nervous system.

And Benedetti’s own body of work has done exactly this. His research group has shown, using naloxone-reversible analgesia, that placebo pain relief in some contexts recruits the same endogenous opioid systems triggered by real analgesics. Conditioning-based placebo effects have been demonstrated to alter dopamine release in Parkinson’s patients’ striatum, measurable via PET imaging. These are not “the power of positive thinking” in some hand-wavy sense—they are specific, mechanistically traceable changes in neurotransmitter systems, produced by verbal suggestion, prior conditioning, and expectation alone.

The Bridge to Contemplative Neuroscience

This is where the Digital Dharma reader should lean in. Every contemplative technology—meditation, breathwork, ritual, intention-setting, even the therapeutic frame around psychedelic-assisted therapy—operates, at least in part, through the same expectation and conditioning circuitry that Benedetti has spent decades mapping.

Consider the parallel structure. A meditator who sits down expecting calm, having been conditioned across hundreds of prior sessions to associate the posture and breath with a shift in nervous system state, is engaging mechanisms strikingly similar to those in a conditioned placebo response. This doesn’t diminish meditation’s effects—it suggests that expectation and conditioning are legitimate causal levers on brain and body, not contaminants to be filtered out of “real” practice. Richard Davidson’s work on neuroplasticity in long-term practitioners and Antoine Lutz’s studies on attentional networks both operate on the premise that repeated mental training reshapes neural architecture. Benedetti’s framework gives us a cleaner vocabulary for how much of a contemplative outcome might be attributable to specific expectation-driven mechanisms versus the broader “response” noise of any intervention—natural fluctuation, attention from a teacher, ritual context, community support.

The same logic illuminates the nocebo side of practice, too. Fear-based framing of meditation retreats, dramatic warnings about “dark night” experiences, or overhyped claims about psychedelic risk can genuinely produce the adverse experiences they warn against—not because the warnings are false, but because expectation is a causal variable in subjective experience, just as it is in clinical pain. This has direct relevance to how practitioners and guides frame preparation for ego dissolution or entheogen work: language itself becomes a psychobiological intervention, for better or worse.

There is also a resonance here with Stephen Porges’ polyvagal theory and the broader gut-brain axis literature—all of these frameworks share a commitment to finding the specific physiological pathway beneath a general subjective report. Benedetti’s insistence on separating response from effect is, in essence, a call for the same rigor across all body-mind research: don’t just note that something changed. Find out what changed and why.

Implications for Practitioners and Researchers

For researchers, Benedetti’s paper is a methodological corrective. If we want to claim that meditation, breathwork, or ritual “works,” we owe it to the phenomenon to ask whether the effect is genuinely mechanistic—involving measurable shifts in cortisol, dopamine, endogenous opioids, default mode network activity—or whether it is largely the by-product of attention, belief, community, and time. Both can be real. Both can be valuable. But conflating them prevents us from ever building a rigorous science of contemplative practice.

For practitioners, the implication is more intimate. The fact that expectation and conditioning can produce measurable neurochemical change is not a debunking of subjective experience—it is a vindication of the idea that mental states are causally potent. The placebo effect, properly understood, is proof that belief has biology. The task of contemplative science, and of Digital Dharma’s broader inquiry into consciousness, is to trace that biology as precisely as Benedetti traces it in the clinic—separating the signal of genuine psychobiological transformation from the noise that surrounds every human change process, so that what remains is not less than mysterious, but more precisely known.